Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caspase 1 pseudogene 1 (CASP1P1) is a human pseudogene related by sequence homology to the caspase-1 gene. Pseudogenes like CASP1P1 result from gene duplication or retrotransposition events and lack the full coding capacity, regulatory elements, or expression to produce a functional protein. While pseudogenes can sometimes act as regulatory elements (e.g., as competing endogenous RNAs or sources of small RNAs), there is no established evidence supporting a direct biological or therapeutic function for CASP1P1 specifically. CASP1P1 is not considered an active therapeutic target nor does it encode a receptor, enzyme, or transporter. The functional caspase-1 gene (CASP1) itself is a cysteine protease involved in inflammation and pyroptosis, but CASP1P1 should not be confused with its functional paralog[2][3].
None (Does not encode a functional molecule for pharmacological action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caspase 1 pseudogene 1 (CASP1P1).